Don’t Give Up on Prostate Cancer Screening Just Yet

	Tweet

What’s a guy to do? While prostate specific antigen (PSA) testing has been the standard screening tool for prostate cancer for several decades, results of a study recently published in The New England Journal of Medicine question the effectiveness of PSA screening in reducing death from prostate cancer. But many urologists argue that men should not be swayed from getting the test—it still saves lives.

Matthew Shuford, M.D., urologist on the medical staff at Baylor University Medical Center at Dallas, sees no reason to give up the PSA screening in light of the recent findings.

“Prostate cancer is the most common cancer in men and the second leading cause of cancer death in men,” says Dr. Shuford. “Keep in mind that it is only curable when caught early; it can only be caught early by screening; and the screening is a simple blood test that is cheap and easy.”

Approximately 90 percent of all prostate cancers are currently diagnosed at an early stage, according to the National Cancer Institute.

“Early diagnosis greatly increases a man’s chances of successful treatment,” adds Dr. Shuford.

Prostate cancer screening includes a digital rectal exam (DRE) and a simple PSA blood test. The American Cancer Society recommends men talk with their physician about a regular screening plan.

While some men might complain that the DRE screening is too uncomfortable and some researchers might suggest that the PSA test is not necessary, Dr. Shuford is quick to compare the screening to other cancer screening tests.

“Colon cancer screening, for example, is a more expensive and a more invasive procedure than prostate cancer screening, involving the increased complications of anesthesia with the added discomfort of a bowel prep,” he said. “This is accepted despite the fact that the vast majority of people will have no abnormality found and even fewer will have colon cancer.”

“What if a blood test existed for colon cancer,” asks Dr. Shuford. “I can’t think of anyone who would say no to a blood test that may let them avoid a colonoscopy,” he said. “This is what the PSA test does for prostate cancer.”

The Baylor Health Care System Foundation is hosting EveryMan®, the first event of its kind in North Texas, to raise funds for prostate cancer research, community outreach and expanded technology throughout the Baylor Health Care System. The event will be held Wednesday, May 13, 2009 at the Ritz Carlton in Dallas. The dinner will feature Rudy Giuliani, former New York City mayor and presidential candidate. Giuliani’s father died of prostate cancer in 1981, and Giuliani himself was diagnosed and successfully treated for the disease in 2000. Ticket and sponsorship opportunities are now available. To learn more about the EveryMan® dinner or to secure tickets, please e-mail with EveryMan® in the subject line or call 214-820-2681.

For more information about Baylor University Medical Center at Dallas, visit http://www.BaylorHealth.com or call 1-800-4BAYLOR.

Source: Baylor Health Care System

RELATED STORIES:
Low-grade prostate cancer may not require aggressive treatment   Prostate technique provides new insights   Biofeedback cuts urine leak after prostate surgery   A low-carb diet may stunt prostate tumor growth   Genetic and Behavioral Differences Add to Prostate Cancer Disparities   Obese Prostate Cancer Patients may benefit More from Brachytherapy   Prostate Cancer - Patterns of Progression   Obesity ups odds that prostate cancer will recur   Novel drug selectively kills prostate cancer cells   University of Oklahoma Scientists Discover Way to Stop Pancreatic Cancer in Early Stages   Gene Linked to Aggressive Prostate Cancer   Prostate cancer patients disease free after 5 years likely to be disease free after 10 years   Program boosts life for prostate cancer patients   Prostate cancer clinical stage does not predict recurrence   Too many old men get prostate cancer tests: study   Blood test indicates spread of prostate cancer   Surgeon’s skill affects prostate cancer relapse   Advanced-Stage Prostate Cancer Patients Experience 20-Year Survival Rates With Surgery   Omega-3s cut risk of advanced prostate cancer   Genetic factors implicated in survival gap for breast, ovarian or prostate cancer   Cancer in sister affects black men’s cancer risk   Obese men less likely to get biopsy after PSA screening

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]